Table 1.

Quantification of CD133+CD34+ cells in proliferating hemangioma




Hemangioma specimen

Patient sex

Patient age, mo

Tumor first noted

CD34+, %

CD133+CD34+, %

CD133+KDR+, %
1   38   F   7   2 wk after birth   45.2   0.18   ND  
2   39   M   7   3 wk after birth   23.2   0.10   ND  
3   41   F   4   At birth   27.2   21.40   ND  
4   46   F   5   At birth   21.6   0.00   ND  
5   49   F   15   1 wk after birth   34.3   0.15   ND  
6   53   M   9   2 mo after birth   49.9   0.67   ND  
7   54   F   19   8 d after birth   69.9   2.91   ND  
8   61   F   3   2 wk after birth   53.4   1.62   ND  
9   73   F   4   2-3 d after birth   50.3   0.20   0.17  
10   74   F   6   At birth   34.6   0.17   0.14  
11   75   F   15   2-3 d after birth   37.8   2.15   1.60  
12
 
77
 
F
 
24
 
At birth
 
69.4
 
0.23
 
0.22
 



Hemangioma specimen

Patient sex

Patient age, mo

Tumor first noted

CD34+, %

CD133+CD34+, %

CD133+KDR+, %
1   38   F   7   2 wk after birth   45.2   0.18   ND  
2   39   M   7   3 wk after birth   23.2   0.10   ND  
3   41   F   4   At birth   27.2   21.40   ND  
4   46   F   5   At birth   21.6   0.00   ND  
5   49   F   15   1 wk after birth   34.3   0.15   ND  
6   53   M   9   2 mo after birth   49.9   0.67   ND  
7   54   F   19   8 d after birth   69.9   2.91   ND  
8   61   F   3   2 wk after birth   53.4   1.62   ND  
9   73   F   4   2-3 d after birth   50.3   0.20   0.17  
10   74   F   6   At birth   34.6   0.17   0.14  
11   75   F   15   2-3 d after birth   37.8   2.15   1.60  
12
 
77
 
F
 
24
 
At birth
 
69.4
 
0.23
 
0.22
 

ND indicates not determined.

or Create an Account

Close Modal
Close Modal